A Novel 5-Methylcytosine- and Immune-Related Prognostic Signature Is a Potential Marker of Idiopathic Pulmonary Fibrosis

Figure 1

The design and main results of this study. IPF: idiopathic pulmonary fibrosis; m5C: 5-methylcytosine.